By Ria Kakkad (Drug Target Review)2023-02-28T15:37:09
The new ‘hybrid’ hydrogel allowed researchers to safely deliver stem cells to the site of a brain injury in mice.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-01-06T16:37:30
Sponsored by Catalent
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-01-09T09:30:19
Sponsored by Sartorius
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud